AI Article Synopsis

  • The study investigates the pharmacokinetics and pharmacodynamics (PK/PD) of pazufloxacin, a drug effective against a bacterium associated with hospital infections.
  • The research involves creating a mouse infection model and measuring pazufloxacin levels using high-performance liquid chromatography to establish its effectiveness.
  • Findings suggest that specific AUC/MIC and C/MIC ratios can optimize dosing regimens, which may help prevent the spread of nosocomial infections.

Article Abstract

The bacterium is known to be associated with nosocomial infections around the world. Pazufloxacin, a potent DNA gyrase inhibitor, is known to be an effective drug candidate. However, it has not been clarified whether the pharmacokinetic (PK)/pharmacodynamic (PD) of pazufloxacin was effective against . . Herein, we demonstrated that the PK/PD index of pazufloxacin against . infection is used to optimize the dosing regiments. We constructed an in vivo infection model by infecting . into the thigh of a mouse to determine the PD, and we measured the serum concentration of pazufloxacin to construct the PK model using high-performance liquid chromatography. The therapeutic efficacy of pazufloxacin was correlated with the ratio of the area under the free concentration time curve at 24 h to the minimum inhibitory concentration (AUC/MIC), and the maximum free concentration to the MIC (C/MIC). Each contribution rate (R) was 0.72 and 0.65, respectively, whereas the time at which the free drug concentration remained above the MIC (R = 0.28). The target value of pazufloxacin AUC/MIC for stasis was 46.1, for 1 log it was 63.8, and for 2 log it was 100.8. Moreover, C/MIC for stasis was 5.5, for 1 log it was 7.1, and for 2 log it was 10.8. We demonstrated that the in vivo concentration-dependent activity of pazufloxacin was effective against the . infection, and successfully made the PK/PD model sufficiently bactericidal. The PK/PD model will be beneficial in preventing the spread of nosocomial infections.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312304PMC
http://dx.doi.org/10.3390/antibiotics11070982DOI Listing

Publication Analysis

Top Keywords

concentration-dependent activity
8
pazufloxacin
8
activity pazufloxacin
8
nosocomial infections
8
pazufloxacin effective
8
free concentration
8
pk/pd model
8
concentration
5
pazufloxacin vivo
4
vivo pharmacokinetic/pharmacodynamic
4

Similar Publications

Safer chemical alternatives to bisphenol (BP) have been a major pursuit of modern green chemistry and toxicology. Using a chemical similarity-based approach, it is difficult to identify minor structural differences that contribute to the significant changes of toxicity. Here, we used omics and computational toxicology to identify chemical features associated with BP analogue-induced embryonic toxicity, offering valuable insights to inform the design of safer chemical alternatives.

View Article and Find Full Text PDF

Introduction: Neuroinflammation derived from the activation of the microglia is considered a vital pathogenic factor of Alzheimer's Disease (AD). T-006, a tetramethylpyrazine derivative, has been found to alleviate cognitive deficits via inhibiting tau expression and phosphorylation in AD transgenic mouse models. Recently, T-006 has been proven to dramatically decrease the levels of total Amyloid β (Aβ) peptide and Glial Fibrillary Acidic Protein (GFAP) and suppress the expression of ionized calcium binding adaptor molecule-1 (Iba-1) in APP/PS1 mice.

View Article and Find Full Text PDF

This study explored the vasodilatory mechanisms of the sodium-glucose cotransporter-2 inhibitor remogliflozin using femoral arteries of rabbits. Remogliflozin dilated femoral arterial rings pre-contracted with phenylephrine in a concentration-dependent manner. Pretreatment with the Ca-sensitive K channel inhibitor (paxilline), the ATP-sensitive K channel inhibitor (glibenclamide), or the inwardly rectifying K channel inhibitor (Ba) did not alter the vasodilatory effect.

View Article and Find Full Text PDF

Synthesis and pharmacological evaluation of natural product diphyllin derivatives against head and neck squamous cell carcinoma.

Eur J Med Chem

December 2024

Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Shanghai, 200011, China; Digital Diagnosis and Treatment Innovation Center for Cancer, Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China. Electronic address:

Head and neck squamous cell carcinoma (HNSCC) is one of the most common malignant tumors, but clinical drug treatments are limited. The natural product diphyllin was identified as a lead compound suppressing the proliferation of HNSCC cells through phenotypic screening of natural product library. However, further developments of diphyllin as an anti-HNSCC agent were restricted by the weak bioactivity and poor metabolic stability.

View Article and Find Full Text PDF

Nelumbo nucifera, an aquatic crop cultivated throughout Asian countries, belongs to the Nelumbonaceae family and has been widely used in traditional medicines with key pharmacological activities such as anti-viral, antipyretic, antioxidant, anti-steroid, anti-inflammatory, anti-arrhythmia, anti-obesity, and anti-aging properties. The present study aims to explore and assess the phytochemical composition, GC-MS profiling, antioxidant efficacy, and the major phytoconstituent phytol subjected to theoretical spectroscopic characterization using the DFT method. The phytochemical profiling of N.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!